JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Khafaji, A. H.
Right arrow Articles by Manning, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Khafaji, A. H.
Right arrow Articles by Manning, H. L.
Related Collections
Right arrow Critical Care
Right arrow Pharmacology

Anesth Analg 2002;94:1583-1585
© 2002 International Anesthesia Research Society

CRITICAL CARE AND TRAUMA

Propylene Glycol Toxicity Associated with Lorazepam Infusion in a Patient Receiving Continuous Veno-Venous Hemofiltration with Dialysis

Ali H. Al-Khafaji, MD, William E. Dewhirst, MD, and Harold L. Manning, MD FCCP

Section of Critical Care Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Address correspondence and reprint requests to Ali H. Al-Khafaji, MD, Section of Critical Care Medicine, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756. Address e-mail to Ali.H.Al-Khafaji{at}Hitchcock.org

IMPLICATIONS: We report a case of toxicity from the drug solvent propylene glycol resulting from prolonged, large-dose lorazepam infusion. The case is unusual in that toxicity developed during continuous veno-venous hemofiltration with dialysis, a renal replacement therapy that should been have been effective at eliminating the chemical and its metabolites.




This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
J. L. Nelsen, C. E. Haas, B. Habtemariam, D. C. Kaufman, A. Partridge, S. Welle, and A. Forrest
A Prospective Evaluation of Propylene Glycol Clearance and Accumulation During Continuous-Infusion Lorazepam in Critically Ill Patients
J Intensive Care Med, May 1, 2008; 23(3): 184 - 194.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
B. W Neale, E. L Mesler, M. Young, J. A Rebuck, and W. J Weise
Propylene Glycol-Induced Lactic Acidosis in a Patient with Normal Renal Function: A Proposed Mechanism and Monitoring Recommendations
Ann. Pharmacother., October 1, 2005; 39(10): 1732 - 1735.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. C. Wilson, C. Reardon, A. C. Theodore, and H. W. Farber
Propylene Glycol Toxicity: A Severe Iatrogenic Illness in ICU Patients Receiving IV Benzodiazepines: A Case Series and Prospective, Observational Pilot Study
Chest, September 1, 2005; 128(3): 1674 - 1681.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2002 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.